Vanguard Group’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-8,053,459
| Closed | -$118M | – | 4352 |
|
|
2025
Q3 | $118M | Sell |
8,053,459
-188,695
| -2% | -$1.92M | ﹤0.01% | 1782 |
|
|
2025
Q2 | $80.9M | Buy |
8,242,154
+1,078,545
| +15% | +$8.93M | ﹤0.01% | 1916 |
|
|
2025
Q1 | $52.1M | Buy |
7,163,609
+1,471,278
| +26% | +$12.9M | ﹤0.01% | 2083 |
|
|
2024
Q4 | $44.5M | Buy |
5,692,331
+686,054
| +14% | +$5.65M | ﹤0.01% | 2210 |
|
|
2024
Q3 | $37M | Buy |
5,006,277
+201,324
| +4% | +$1.69M | ﹤0.01% | 2307 |
|
|
2024
Q2 | $38.5M | Buy |
4,804,953
+81,982
| +2% | +$732K | ﹤0.01% | 2252 |
|
|
2024
Q1 | $55M | Buy |
4,722,971
+415,386
| +10% | +$4.6M | ﹤0.01% | 2128 |
|
|
2023
Q4 | $48.1M | Buy |
4,307,585
+781,803
| +22% | +$7.19M | ﹤0.01% | 2204 |
|
|
2023
Q3 | $54.4M | Buy |
3,525,782
+155,841
| +5% | +$2.62M | ﹤0.01% | 2089 |
|
|
2023
Q2 | $63.9M | Buy |
3,369,941
+763,656
| +29% | +$13.4M | ﹤0.01% | 2082 |
|
|
2023
Q1 | $39.7M | Buy |
2,606,285
+1,027,990
| +65% | +$13.4M | ﹤0.01% | 2277 |
|
|
2022
Q4 | $20.1M | Sell |
1,578,295
-93,289
| -6% | -$839K | ﹤0.01% | 2627 |
|
|
2022
Q3 | $9.68M | Buy |
1,671,584
+683,232
| +69% | +$3M | ﹤0.01% | 2964 |
|
|
2022
Q2 | $3.18M | Buy |
988,352
+582,933
| +144% | +$1.76M | ﹤0.01% | 3600 |
|
|
2022
Q1 | $1.53M | Sell |
405,419
-110,725
| -21% | -$713K | ﹤0.01% | 4064 |
|
|
2021
Q4 | $6.75M | Sell |
516,144
-90,770
| -15% | -$1.44M | ﹤0.01% | 3446 |
|
|
2021
Q3 | $11.9M | Buy |
606,914
+174,979
| +41% | +$3.2M | ﹤0.01% | 3143 |
|
|
2021
Q2 | $8.08M | Sell |
431,935
-6,758
| -2% | -$151K | ﹤0.01% | 3321 |
|
|
2021
Q1 | $10.4M | Buy |
438,693
+18,891
| +4% | +$436K | ﹤0.01% | 3122 |
|
|
2020
Q4 | $10.2M | Sell |
419,802
-128,617
| -23% | -$3.29M | ﹤0.01% | 2982 |
|
|
2020
Q3 | $14.1M | Buy |
548,419
+289,589
| +112% | +$9.19M | ﹤0.01% | 2615 |
|
|
2020
Q2 | $5.16M | Buy |
258,830
+164,947
| +176% | +$4.01M | ﹤0.01% | 3089 |
|
|
2020
Q1 | $2.37M | Buy |
93,883
+1,406
| +2% | +$41.1K | ﹤0.01% | 3256 |
|
|
2019
Q4 | $2.43M | Buy |
+92,477
| New | +$2.57M | ﹤0.01% | 3396 |
|
Other funds holding ETNB
Vanguard Group's ETNB Position: Q4 2025 in Review
Vanguard Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 8,053,459 shares — an estimated $118M sold.
Vanguard Group first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $118M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Vanguard Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Vanguard Group sold 8,053,459 89bio shares in Q4 2025, an estimated $118M.
- Vanguard Group first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
- Vanguard Group's 89bio position peaked at $118M in Q3 2025.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.